FACTORS ASSOCIATED WITH MEDICATION ADHERENCE AMONG HYPERTENSIVE PATIENTS: THE ROLE OF FAMILY SUPPORT AND DURATION OF HYPERTENSION AT TOTO KABILA REGIONAL HOSPITAL

Abstract

Medication adherence is a key component of effective hypertension management. Poor adherence to antihypertensive therapy remains a major challenge and contributes to uncontrolled blood pressure and an increased risk of cardiovascular complications. Family support and disease duration have been identified as important determinants of medication adherence, yet evidence from local healthcare settings remains limited. This study aimed to examine the association between family support, duration of hypertension, and medication adherence among hypertensive patients at Toto Kabila Regional Hospital. A quantitative analytical study with a cross-sectional design was conducted among 23 hypertensive patients selected using purposive sampling. Family support was assessed using a structured 15-item questionnaire, while medication adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS-8). Data were analyzed using descriptive statistics and the Chi-square test with a significance level of p < 0.05. Most respondents had experienced hypertension for less than one year (56.6%). Good medication adherence was observed in 56.6% of respondents, whereas 43.4% demonstrated poor adherence. Chi-square analysis revealed a significant association between family support and medication adherence (p < 0.001). Likewise, the duration of hypertension was significantly associated with medication adherence (p < 0.001). Respondents who received greater family support tended to demonstrate better adherence to antihypertensive therapy. Family support and duration of hypertension were significantly associated with medication adherence among hypertensive patients. Strengthening family involvement and providing continuous support for patients with long-standing hypertension may improve long-term adherence and optimize hypertension management.